Song Hyung Keun, Sohn Young Bae, Choi Yong Jun, Chung Yoon-Sok, Jang Ja-Hyun
Department of Orthopedic Surgery Department of Medical Genetics Department of Endocrinology and Metabolism, Ajou University Hospital, Ajou University School of Medicine, Suwon Green Cross Genome, Yongin, Republic of Korea.
Medicine (Baltimore). 2017 Mar;96(12):e6367. doi: 10.1097/MD.0000000000006367.
Pycnodysostosis is a rare autosomal recessive skeletal dysplasia characterized by short stature, craniofacial dysmorphism, acro-osteolysis, osteosclerosis, and brittle bone with poor healing. Pycnodysostosis results from the deficient activity of cathepsin K, a lysosomal cysteine protease that is encoded by CTSK.
We report a Korean adult patient with pycnodysostosis and atypical femur fracture whose diagnosis was confirmed by next-generation sequencing (NGS) of candidate genes. A 41-year-old female patient was presented with a left femur fracture after falling down. Underlying sclerotic bone disease was suspected as a radiographic skeletal survey showed thickened cortical bones, and the total body bone density was increased (T score was 5.3, and Z score was 4.9).
We performed candidate gene sequencing of various sclerotic bone diseases for the differential molecular diagnosis of underlying sclerosing bone disease. Two heterozygous variants of CTSK were detected. One was a frameshift variant in exon 5, c.426delT (p.Phe142Leufs*19), which was previously reported, and the other was a novel missense variant in exon 6, c.755G>A (p.Ser252Asn). Sanger sequencing of CTSK confirmed the 2 heterozygous variants and thus the patient was diagnosed with pycnodysostosis.
The patient had emergency surgery for subtrochantic femoral fracture.
After 4 months of surgery, the patient had almost a full range of hip and knee movements and radiographs show the substantial bridging callus across the fracture.
Candidate gene sequencing could be a useful diagnostic tool for the genetically heterogeneous skeletal dysplasia group, especially in cases with a mild or atypical clinical phenotype.
致密性骨发育不全是一种罕见的常染色体隐性遗传性骨骼发育不良,其特征为身材矮小、颅面畸形、肢端骨质溶解、骨质硬化以及骨折后骨愈合不良。致密性骨发育不全是由组织蛋白酶K活性不足所致,组织蛋白酶K是一种溶酶体半胱氨酸蛋白酶,由CTSK编码。
我们报告一名患有致密性骨发育不全和非典型股骨骨折的韩国成年患者,其诊断通过候选基因的二代测序(NGS)得以证实。一名41岁女性患者跌倒后出现左股骨骨折。由于X线骨骼检查显示皮质骨增厚且全身骨密度增加(T值为5.3,Z值为4.9),怀疑存在潜在的硬化性骨病。
我们对各种硬化性骨病进行候选基因测序,以对潜在的硬化性骨病进行鉴别分子诊断。检测到CTSK的两个杂合变异。一个是外显子5中的移码变异,c.426delT(p.Phe142Leufs*19),此变异先前已有报道,另一个是外显子6中的新错义变异,c.755G>A(p.Ser252Asn)。CTSK的Sanger测序证实了这两个杂合变异,因此该患者被诊断为致密性骨发育不全。
患者接受了股骨转子下骨折的急诊手术。
术后4个月,患者髋关节和膝关节活动范围基本正常,X线片显示骨折处有大量骨痂形成。
候选基因测序对于遗传异质性骨骼发育不良组可能是一种有用的诊断工具,尤其是在临床表型轻微或不典型的病例中。